Diabetic Retinopathy in African Americans: Vision Impairment, Prevalence, Incidence, and Risk Factors

International Ophthalmology Clinics

Volumn 43, Issue 4, 2003, Pages 105-122

  Baker, Richard S ^a  

^a CHARLES R DREW UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLINDNESS; BLOOD PRESSURE REGULATION; DIABETES CONTROL; DIABETIC RETINOPATHY; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH EDUCATION; HEALTH INSURANCE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; HYPERTENSION; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; MEDICARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; REGISTER; RETINA MACULA EDEMA; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; VISUAL IMPAIRMENT;

EID: 0142183498     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004397-200304340-00011     Document Type: Review

References (80)

1. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population: the Baltimore Eye Survey. Arch Ophthalmol 1990;108:286-290
2. West SK, Munoz G, Rubin GS, et al. Function and visual impairment in a population-based study of older adults. Invest Ophthalmol Vis Sci 1997;38:72-82
3. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics fact sheet: general information and national estimates on diabetes in the United States, 2000. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, Publication No. 02-3892
4. Lipton RB, Liao Y, Cao G, et al. Determinants of incident non-insulin dependent diabetes mellitus among blacks and whites in a national sample: The NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1993;138:826-839
5. Tull ES, Roseman JM. Diabetes in African Americans. In: Diabetes in America, ed 2. (NIH Publication No. 95-1468, 613-630). Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Health, 1995. (Available at: http://www.n.ddk.nih.gov/health/diabetes/dia/.
6. National Institute of Diabetes and Digestive and Kidney Diseases. National diabetes statistics fact sheet: diabetes in African Americans. Bethesda, MD: U.S. Department of Health and Human Services, National Institute of Health, publication No. 02-3266
7. Davidson MB. The disproportionate burden of diabetes in African-American and Hispanic populations. Ethn Dis 2001;11(1):148-151
8. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996;125:221-232
9. Rabb MF, Gagliano DA, Sweeney HE. Diabetic retinopathy in blacks. Diabetes Care 1990;13(11):1202-1206
10. Roy MS. Diabetic retinopathy in African Americans with type 1 diabetes: The New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch Opthalmol 2000;118(1):97-104
11. Kini MM, Leibowitz HM, Colton T, et al. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open angle glaucoma in the Framingham Eye Study. Am J Ophthalmol 1978;85:28-34
12. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 1984;102:520-526
13. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 or more years. Arch Ophthalmol 1984;102:527-532
14. Klein R, Klein BEK, Moss SE, et al. The Beaver Dam Eye Study: Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology 1992;99:58-62
15. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiology Study of Diabetic Retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-1228
16. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993;329:977-986
17. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS Report No. 8. Ophthalmology 1981;88:583-600
18. Harris EL, Sherman SH, Georgopoulos A. Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes. Diabetes Care 1999;22(5):779-783
19. National Eye Institute. NEI strategic plan on reducing health disparities. FY 2000-2004. http://www.nei.nih.gov/resources/straegicplans/disparities.htm
20. Klein R, Klein BEK. Vision disorders in diabetes. In: Diabetes in America, ed 2. (NIH Publication No. 95-1468, 293-338) Bethesda, MD: National Diabetes Data Group National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1995
21. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974;78(1):58-67
22. Sommer A, Tielsch JM, Katz J, et al. Racial differences in Cause-Specific prevalence of blindness in East Baltimore. N Engl J Med 1991;325:1412-1417
23. Rahmani B, Tielsch JM, Katz J, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996;103(11): 1721-1726
24. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans: The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000;118(6):819-825
25. Harris MI, Klein R, Cowie CC, et al. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican Americans than in non-Hispanic whites with type 2 diabetes? A U.S. population study. Diabetes Care 1998;21(8):1230-1235
26. Klein R, Sharrett AR, Klein BE, et al. The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 2002;109(7):1225-1234
27. National Society to Prevent Blindness. Vision problems in the U.S. Prevalence of adult vision impairment and the age-related eye disease in America. New York: National Society to Prevent Blindness, 1980
28. Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology 1999;106(10):1893-1899
29. Mitchell P, Smith W, Wang JJ, et al. Prevalence of diabetic retinopathy in an older community. Ophthalmology 1998;105:406-411
30. Hyman L, Wu SY, Connell AM, et al. Prevalence and causes of visual impairment in The Barbados Eye Study. Ophthalmology 2001;108(10):1751-1756
31. Klein R, Klein B, Moss S, et al. Association of ocular disease and mortality in a diabetic population. Archives of Ophthalmology 1999;117:1487-1495
32. Klein R, Klein B, Moss S. Epidemiology of proliferative diabetic retinopathy. Diabetes Care 1992;15:1875-1891
33. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998;21:1138-1145
34. Lipton R, Good G, Mikhaalov T, et al. Ethnic differences in mortality from insulin-dependent diabetes mellitus among people less than 25 years of age. Pediatrics 1999;103:952-956
35. Klein R, Marino EK, Kuller LH, et al. The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 2002;86(1):84-90
36. Arfken CL, Reno PL, Santiago JV, Klein R. Development of proliferative diabetic retinopathy in African-Americans and whites with type 1 diabetes. Diabetes Care 1998;21 (5):792-795
37. Vitale S, Maguire MG, Murphy RP, et al. Clinically significant macular edema in type I diabetes. Incidence and risk factors. Ophthalmology 1995;102(8):1170-1176
38. Harris EL, Feldman S, Robinson CR, et al. Racial differences in the relationship between blood pressure and risk of retinopathy among individuals with NIDDM. Diabetes Care 1993;16(5):748-754
39. Harris MI, Eastman RC, Cowie CC, et al. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care 1999;22:403-408
40. Weatherspoon LJ, Kumanyikea SK, Ludlow R, et al. Glycemic control in a sample of black and white clinic patients with NIDDM. Diabetes Care 1994;17:1148-1153
41. Wisdom J, Fryzek JP, Havslod SL, et al. Comparison of laboratory test frequency and test results between African Americans and Caucasians with diabetes opportunity for improvement: findings from a large urban health maintenance organization. Diabetes Care 1997;20:971-977
42. Harris MI. Non-insulin dependent diabetes mellitus in black and white Americans. Diabetes Metab Rev 1990;6:71-90
43. Cowie CC, Harris MI. Physical and metabolic characteristics of persons with diabetes. In: Diabetes in America, ed 2. (NIH Publication No. 95-1468, 117-156) Bethesda, MD: National Diabetes Data Group, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, 1995
44. Klein R, Klein BEK, Moss SE, et al. Glycosylated hemoglobin predict the incidence and progress of diabetic retinopathy. JAMA 1988;260:2864-2871
45. Stratton IM, Kohner EM, Aldington SJ, et al. UKPDS50: risk factors for incidence and progression of retinopathy in type 2 diabetes over 6 years from diagnosis. Diabetologia 2001;44:156-163
46. Adler AI, Stratton IM, Neil HA, et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36) prospective observational study. BMJ 2000;321:412-419
47. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiology Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 1998;105:1801-1815
48. Klein R. Prevention of visual loss from diabetic retinopathy. Surv Ophthalmol 2002;47 (suppl)2:S246-S252
49. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulfonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33). Lancet 1998;352:837-853
50. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
51. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796-1806
52. The Diabetic Retinopathy Vitrectomy Research Study Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: two-year results of a randomized trial. Diabetic Retinopathy Vitrectomy Survey Report 2. Arch Ophthalmol 1985;103:1644-1652
53. Ferris FL III. How effective are treatments for diabetic retinopathy? JAMA 1993;269:1290-1291
54. Wang F, Javitt JC. Eye care for elderly Americans with diabetes mellitus. Ophthalmology 1996;103:1744-1750
55. Javitt JC. Preventing blindness in Americans: the need for eye health education. Surv Ophthalmol 1995;40:41-44
56. Javitt JC. Universal coverage and preventable blindness. Arch Ophthalmol 1994;112:453
57. Baker RS, March GA, Scott CT. Blindness and visual impairment in African-American elderly: causes, consequences, and management. Clin Geriatr 1998;6:45-64
58. Seddon JM. The differential burden of blindness in the United States. N Engl J Med 1991;325:1440-1441
59. Blendon RJ, Aiken LH, Freeman HE, et al. Access to medical care for black and white Americans. JAMA 1989;261:278-281
60. Appiah AP, Ganthier R Jr, Watkins N. Delayed diagnosis of diabetic retinopathy in black and Hispanic patients with diabetes mellitus. Ann Ophthalmol 1991;23(4):156-158
61. Baker RS, Watkins NL, Wilson MR, et al. Demographic and clinical characteristics of patients with diabetes presenting to an urban public hospital ophthalmology clinic. Ophthalmology 1998;105:1373-1379
62. Wylie-Rose J, Basch C, Walker EA, et al. Ophthalmic referral rates for patients with diabetes in primary-care clinics located in disadvantaged urban communities. J Diabetes Complications 1995;9:49-54
63. Sprafka JM, Fritsche TL, Baker RS, et al. Prevalence of undiagnosed eye disease in high-risk diabetic individuals. Arch Intern Med 1990;150:857-861
64. Chin MH, Cook S, Jin L, et al. Barriers to providing diabetes care in community health centers. Diabetes Care 2001;24:268-274
65. Walker EA, Basch CE, Howard CJ, et al. Incentives and barriers to retinopathy screening among African-Americans with diabetes. J Diabetes Complications 1997;11(5):298-306
66. Wang F, Javitt JC, Tielsch JM. Racial variations in treatment for glaucoma and cataract among Medicare recipients. Ophthalmic Epidemiol 1997;4(2):89-100
67. Chin MH, Zhang JX, Merrell K. Diabetes in the African-American Medicare population: morbidity, quality of care, and resource utilization. Diabetes Care 1998;21:1090-1095
68. Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in Medicare managed care. JAMA 2002;287(10):1288-1294
69. Brechner RJ, Cowie CC, Howie LJ, et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993;270:1714-1718
70. Harris MI. Racial and ethnic differences in health care access and health outcomes for adults with type 2 diabetes. Diabetes Care 2001;24:454-459
71. Walker EA, Zybert PA, Basch CH. Observations: What is the sensitivity and specificity of self-report for retinopathy screening? [letter]. Diabetes Care 2002;25:933-934
72. Pasagian-Maculay A, Basch CE, Zybert P, et al. Ophthalmic knowledge and beliefs among women with diabetes. Diabetes Educ 1997;23:433-437
73. Reno PL, Arfken CL, Heins JM, et al. Factors that influence the decision to receive treatment for proliferative diabetic retinopathy. Diabetes Educ 1997;23(6):653-655
74. Will JC, German RR, Schurman E, et al. Patient adherence to guidelines for diabetes eye care: results from the diabetic eye disease follow-up study. Am J Public Health 1994;84(10):1669-1671
75. Basch CE, Walker EA, Howard CJ, et al. The effect of health education on the rate of ophthalmic examinations among African Americans with diabetes mellitus. Am J Public Health 1999;89(12):1878-1882
76. Fong DS. Changing times for the management of diabetic retinopathy. Surv Ophthalmol 2002;47(suppl 2):S238-S245
77. Oswald N. Improving quality of care for Californians with diabetes. July 2002. http://www.chcf.org/documents/caredelivery/ImprovingQualityDiabetes.pdf
78. Anderson RM, Wolf FM, Musch DC, et al. Conducting community-based, culturally specific, eye disease screening clinics for urban African Americans with diabetes. Ethn Dis 2002;12(3):404-410
79. Flowers CW, Baker RS, Khanna S, et al. Teleophthalmology: rationale, current issues, future directions. Telemed J 1997;3:43-52
80. Cummings DM, Morrissey S, Barondes MJ, et al. Screening for diabetic retinopathy in rural areas: the potential of telemedicine. J Rural Health 2001;17(1):25-31